Skip to content

Use of ADHEAR, a Non-Implantable Bone Conduction Hearing System, in Children With Single Sided Deafness and/or Conductive Hearing Loss

Subjective Satisfaction and Audiological Benefit With ADHEAR Audio Processor and ADHEAR Adhesive Adapter in Children

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03327194
Enrollment
10
Registered
2017-10-31
Start date
2018-01-31
Completion date
2019-12-01
Last updated
2018-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Conductive Hearing Loss, Single Sided Deafness

Brief summary

A hearing loss affects the quality of life and the natural development of children. The new generation of hearing devices provides a huge number of options to them. These new hearing aids are often aesthetically acceptable, less invasive and user-friendly. The ADHEAR Non-Implantable Bone Conduction Hearing System is connected directly to the skin with a special adhesive adapter. The device transmits the sound to the mastoid by vibrating on the skull and stimulates the inner ear without any previous surgery. The objective of this study is to evaluate of the audiological benefit and subjective satisfaction of ADHEAR Audio Processor with Adhesive attachment in a group of children suffering from conductive hearing loss and/or single sided deafness.

Interventions

DEVICEADHEAR Audio Processor

ADHEAR Audio Processoris a non-invasive bone conduction hearing device which is retained on the patient's head with an adhesive adapter that is placed behind the auricle. The ADHEAR Audio Processor transmits sounds to the mastoid by vibrating on the skull and stimulates the inner ear without any previous surgery. ADHEAR Audio Processor is classified as a Class lla medical device and ADHEAR Adhesive Adapter is classified as a Class I medical device. The ADHEAR Audio Processor has the CE mark.

Sponsors

MED-EL Elektromedizinische Geräte GmbH
CollaboratorUNKNOWN
Queen Fabiola Children's University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Monocentric prospective interventional single-subject design

Eligibility

Sex/Gender
ALL
Age
5 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Unilateral and/or bilateral CHL (e. g. BC-thresholds \<25dB HL) * Ability to perform all tests required for the study * Signed, and dated informed consent by parents and children where applicable

Exclusion criteria

* intolerant of the materials * patient with a skin or scalp condition that may preclude the attachment of the adhesive plaster * fluctuation of hearing loss over a two year period of 15dB in either direction * retrocochlear, or central auditory disorders * any physical, psychological, or emotional disorder that would interfere with the ability to perform on test and rehabilitation procedures

Design outcomes

Primary

MeasureTime frame
Maximal decibels gain measured by Audiological basic testsWeek 3
Maximal decibels gain measured by speech reception threshold in quietWeek 3

Secondary

MeasureTime frameDescription
Comparison of maximal decibels gain measured by speech reception threshold in quiet between ADHEAR Audio Processor and Cochlear bone anchored hearing aidDay 0
Change from baseline in patient and parents satisfaction measured by the ADHEAR Questionnaireweek 3
Change from baseline in Quality of Life measured by the SSQ12 questionnaireweek 3
Average time of daily use of ADHEAR Systemweek 3Adherence reported by patient on a diary card.
Incidence of device-emergent adverse event.Up to 1 year after start of study device utilizationNumber of participants with device-related adverse events as assessed by CTCAE v4.0
Number of subjects who discontinue study device utilization due to any AE or dissatisfactionYear 1
Comparison of maximal decibels gain measured by Audiological basic tests between ADHEAR Audio Processor and Cochlear bone anchored hearing aid.Day 0

Countries

Belgium

Contacts

Primary ContactAmélia Favoreel
amelia.favoreel@huderf.be0032 2 477 24 71
Backup ContactJenne Keyen
jenne.keyen@huderf.be0032 2 477 24 71

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026